Patients and the public deserve big changes in evaluation of drugs

被引：59

作者：

Garattini, Silvio ^{[1
]}

Chalmers, Iain ^{[2
]}

机构：

[1] Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy

[2] Summertown Pavil, Oxford OX2 7LG, England

来源：

BRITISH MEDICAL JOURNAL | 2009年 / 338卷

关键词：

PHARMACEUTICAL-INDUSTRY; RANDOMIZED-TRIALS; HEALTH; INFORMATION; DISCLOSURE; LAW;

D O I：

10.1136/bmj.b1025

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 30 条

[1]

[Anonymous], SIGNIFICANCE

[2]

*ASS BRIT PHARM IN, 2008, ABPI BEST PRACT MOD

[3] Drug industry weakens US bill about disclosure of gifts to doctors [J].

Burton, Bob .

BRITISH MEDICAL JOURNAL, 2008, 336 (7656) :1268-1268

[4]

CAPO IV, 2003, GAZZETTA UFFICIA 1 S, V274, P95

[5]

Chalmers I, 2005, CLIN TRIALS, V2, P229

[6] From optimism to disillusion about commitment to transparency in the medico-industrial complex [J].

Chalmers, Iain .

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2006, 99 (07) :337-341

[7] Empirical evidence for selective reporting of outcomes in randomized trials -: Comparison of Protocols to published articles [J].

Chan, AW ;

Hróbjartsson, A ;

Haahr, MT ;

Gotzsche, PC ;

Altman, DG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (20) :2457-2465

[8]

*CMR INT, 2006, 2006 GLOB R D PERF M, P7

[9] UK government will tighten law on trial results after weaknesses found in safety legislation [J].

Coombes, Rebecca .

BRITISH MEDICAL JOURNAL, 2008, 336 (7644) :576-577

[10]

*DEP TRAD IND, R D SCOR 2006 TOP 80

← 1 2 3 →